ResearcherFudan UniversityActive in the last 2 years
Baian Tao
Matched on OpenAlex author ID A5085598814. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2022: 3 papers · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers
Papers 6
- HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Patients. Co-author DOI 10.1177/15330338261469099↗
- Extracellular vesicles from chemotherapy-induced senescent tumor cells reprogram hepatic phospholipid metabolism to promote pancreatic cancer liver metastasis. Co-author DOI 10.1186/s13046-026-03741-3↗
- Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. First author DOI 10.1186/s12967-024-05363-9↗
- High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3 Signaling Pathway. Co-author DOI 10.1155/2022/3243647↗
- Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Induced by MDR1 and MRP1 Overexpression in … Co-author DOI 10.3389/fsurg.2022.890412↗
- CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14215434↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Jichun Gu · 5 shared papers, 2022–2026 · strength 0.94
- Paper Extracellular vesicles from chemotherapy-induced senescent tumor cells reprogram hepatic phospholipid metabolism to pro… DOI 10.1186/s13046-026-03741-3↗
- Paper Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. DOI 10.1186/s12967-024-05363-9↗
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Deliang Fu · 3 shared papers, 2022–2024 · strength 0.52
- Paper Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. DOI 10.1186/s12967-024-05363-9↗
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Paper CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14215434↗
- Deliang Fu · 2 shared papers, 2022–2026 · strength 0.48
- Paper HRD Score: A Promising Biomarker for Genomic Instability Evaluation for Targeted Treatments Among Pancreatic Cancer Pat… DOI 10.1177/15330338261469099↗
- Paper High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3… DOI 10.1155/2022/3243647↗
- Junyuan Deng · 3 shared papers, 2022 · strength 0.46
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Paper High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3… DOI 10.1155/2022/3243647↗
- Paper CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14215434↗
- Lei Kong · 3 shared papers, 2022 · strength 0.46
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Paper High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3… DOI 10.1155/2022/3243647↗
- Paper CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14215434↗
- Jiali Du · 3 shared papers, 2022 · strength 0.46
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Paper High Glucose Promotes Pancreatic Ductal Adenocarcinoma Gemcitabine Resistance and Invasion through Modulating ROS/MMP-3… DOI 10.1155/2022/3243647↗
- Paper CDCA8/SNAI2 Complex Activates CD44 to Promote Proliferation and Invasion of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14215434↗
- Ji Li · 2 shared papers, 2022–2024 · strength 0.37
- Paper Integrating plasma protein-centric multi-omics to identify potential therapeutic targets for pancreatic cancer. DOI 10.1186/s12967-024-05363-9↗
- Paper Gemcitabine-Loaded Albumin Nanoparticle Exerts An Antitumor Effect on Gemcitabine-Resistant Pancreatic Cancer Cells Ind… DOI 10.3389/fsurg.2022.890412↗
- Hengchao Li · 2 shared papers, 2022–2024 · strength 0.36
- Xiaoyi Wang · 1 shared paper, 2026 · strength 0.33
- Deliang Fu · 1 shared paper, 2026 · strength 0.27
- Siyu Zhou · 1 shared paper, 2024 · strength 0.21
- Shu‐Heng Jiang · 1 shared paper, 2024 · strength 0.21
- Chen Jin · 1 shared paper, 2022 · strength 0.16
- Ji Li · 1 shared paper, 2022 · strength 0.15
- Ji Li · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.